Title: The problems of transplanting animal organs
1The problems of transplanting animal organs into
humans
Jenny Kukielski
Jeong Ryul Lee, M.D. Pediatric Cardiac
Surgery Seoul National University Hospital
2The end of the night shift Organ transplantation
today and tomorrow
- The future
- Donor center
- Regular working hour
- 200 procedures a day
- daily-base available
- The present
- Telephone at 2 AM
- A car-accident donor
- 1-2 hour-drive for harvest
- Get back to hospital at 7 AM
- Heart transplantation
- Continue regular cases
3Animal attraction (1) Supply and demand in the
world of organ transplantation
- The heart patient
- 14 year old previously healthy boy
- Virus induced cardiomyopathy
- ICU care for 3 weeks
- Boys heart failure getting worse
- Listed in heart transplantation
- Transfer to LVAD available center
- Risk during transportation
- The harsh statistics
- 63000 waiting for organ in USA
- Listing for organ every 18 minutes
- Average waiting over 1 year
4(No Transcript)
5(No Transcript)
6(No Transcript)
7Animal attraction(2) Supply and demand in the
world of organ transplantation
- Closing the donor-recipient gap
- Raising the possibilities of organ donation
- Presumed consent donation unless objection
- Draw attention from public with newsworthy
people - Donor rate 10-30/ million
- Donor rate of hospital death 4
- Living donors
- Increasing unrelated living donor
- Organ brokers the ethical dilemma
- Arrange dealing organs from poverty-stricken man
- Rewarded gifting
8Animal attraction(3) Supply and demand in the
world of organ transplantation
- The real extent of the problem
- Legal and cultural barrier
- The borderline candidates
- Limited potential of artificial organs
9From Icarus to the first transplant(1) Mans
first attempts to bridge the species gap
- Daedalus and Icarus in mythology feather into
arm - 1921 Paris, Sexual rejuvenation by xenografting
(baboon) - Reemtsma Tongue into cheek
- 1628 Italy, Blood transfusion from sheeps to
humans - 1682 Russia, Dog skull into human skull
- 1880 Chicago, Dr.Lees Lamb, Pedicled skin
graft - 1800s The fashion for frogs, Skin graft
- 1907 Alexis Carrel, Vessel anastomosis
10From Icarus to the first transplant(2) Mans
first attempts to bridge the species gap
- Transplantation of kidney
- 1902, Emerich Ullman, Vienna Pig kidney to
human arm vessel - 1905, Princeteau, French Rabbit kidney slices
to child kidney - 1906, Matheu Jaboulay, Frenchpig and goat
kidney to human arm - 1910, Ernest Unger monkey kidney to human
/stillbirth human kidney to baboon - 1963, Keith Reemtsma, Louisiana,13 chimpanzee
kidney into human - 1964, Tom Starzl, Colorado, 6 baboon kidney into
human(17-60d)
11From Icarus to the first transplant(3) Mans
first attempts to bridge the species gap
- Transplantation of animal heart
- 1964, James Hardy, U Mississippi chimpanzee
heart to human , size mismatch - 1968, Denton Cooley, Donald Ross, Texas and
London sheep and pig heart to human - 1977, Christian Barnard, Cape Town chimpanzee
and baboon heart as auxiliaries - 1984, Leonard Bailey, Loma Linda Baby Fae (20d)
- 1992, Poland, Pig heart to human(24h)
- 1996, India (0d)
12From Icarus to the first transplant(4) Mans
first attempts to bridge the species gap
- Transplantation of animal livers
- 1992, Tom Starzl Pittsburgh, baboon liver to
human(70d with vigorous immunosuppression) - Extracorporeal liver perfusion, USA, South Africa
13All animals are equal, but some are more equal
than others The choice of donor
- Candidate number 1 The great apes
- The closeness of phylogenetic relationships
(98) - Time-consuming and expensive source of organs
- Poor public consensus
- Their scarcity problem
14All animals are equal, but some are more equal
than others The choice of donor
- Candidate number 2 The baboon
- Non-human primate
- Sufficient number
- Closed breeding possible
- Possible virus transmission
- Size mismatch (40kg adult)
- One offspring
- Sexual maturation by 3-5 years
- 9 years for adult sized growth
- Consistency in different environment (thick
bile) - Risk of infection AIDS, SV,
- Poor public compliance
15All animals are equal, but some are more equal
than others The choice of donor
- Candidate number 3 The pig(1)
- Less public controversy
- Sufficient number
- Reproductive maturity within 6 months
- Sows mating capable every 3 weeks
- Pregnancy less than 4 months (3m3w3d)
- Easy and cheap to maintain
- Rapid growth (1year to adult size)
- Miniature pigs (Pigmees) well matching in size
- Similar anatomy and physiology to human
- Both pigs and humans omnivorous
- Extensively studied animal
16All animals are equal, but some are more equal
than others The choice of donor
- Candidate number 3 The pig(2)
- Potential for genetic engineering
- Less worrisome zoonosis
- Pig disease and defects ( 0.004 cancer )
- Tissue typing in pig ( Class IIClass I)
- Weak blood group antigen expression
- To be in the center of the study ( humanized/
disease free)
17Zero tolerance The rejection of animal organs
- The power of nature
- The most powerful immunological reaction
- Safety tools to defend against microorganisms
- A reflex reaction to foreign threat
- The human bodys oldest and strongest natural
survival mechanism
18Zero tolerance The rejection of animal organs
- Transplantation between closely related animals
- Antibody- or AntibodyCell mediated
- Large dose immunosuppression months
- Inevitable risk of infection, drug related
complication - Inevitable chronic rejection
19Zero tolerance The rejection of animal organs
- Transplantation between distantly related
animals - The first barrier Hyperacute rejection
- Antibody already circulating in large numbers
- The nature of anti pig antibodies
- Surgeons and scientist from Oklahoma(Eugen Koren
from Croatia, 1991) Alberta(Heather Good) - Galactose
- Uri Galili, Biological detective Only human,
great ape, old world monkey capable of Ab
production - The remaining barriers peeling an onion
- NK, macrophage
- Cellular rejection
20(No Transcript)
21The Spoonful of Sugar Prevention of rejection
- Overcoming the first hurdle
- Preventing hyperacute rejection(1)
- Perfusion of recipient serum into first pig
organ - Refining the technique Plasma exchange with
immunosuppressionsplenectomy - Being more specific depleting anti-Gal
antibodies - Accommodating the transplanted organs after
2-3wk of depletion of Abs - The pioneering work Guy Alexandre (Belgian)
- Replace serum with saline or innocuous solution
- Splenectomy immunosuppression
- ABO incompatible kidney transplantation
22The Spoonful of Sugar Prevention of rejection
- Overcoming the first barrier
- Preventing hyperacute rejection(2)
- Egidio Romanos new concepts
- Antibody inhibition by injectable sugar
- To remove anti-A antibody for A type blood
- The scientist as a guinea pig
- Therapy at 1 million a day 90/mg of sugar
(Chembiomed Ltd.) - Gal-filled cartridge less expensive
- Anti-idiotype antibody antibodies against
antibodies - Mouse anti- anti-pig antibodies
- Depletion or inhibition of complement
- CVF rapid complement consumption
- Soluble complement factor 1 (Fred Sanfilippo
from Johns Hopkins)
23(No Transcript)
24The Spoonful of Sugar Prevention of rejection
- Overcoming the second barrier
- Preventing Delayed antibody-mediated rejection
- Antibody-mediated without complement
- Fritz Bach from Beth-Israel, Jeff Platt from
Duke - The right immunosuppressive combinations
maintenance of low anti-pig antibodies
25The Spoonful of Sugar Prevention of rejection
- Overcoming the third barrier
- Preventing acute cellular rejection
- Antirejection drugs
- Azathioprine, British, Sir Roy Calne (1960s)
killing dividing T-cell - Corticosteroid suppress T-cell
- ATG/ALS Rabbit antihuman-T-cell antibodies, Sir
Michael Woodruff(British), Anthony Monaco and
Paul Russell(Harvard surgeon) - Cyclosporine (late 1970s) inhibition of T-cell
function - Jean Borel, Swiss immunologist, Sandoz, now
Norvatis) - Sir Roy Calne, David White, British experiment
- OKT3 Killing T-cell
- Ben Cosimi, MGH
- Mouse anti-T-cell antibodies
- Tacrolimus, Tom Starzl competing cyclosporine
- Mycophenolate mofetil replace azathioprine
26The Spoonful of Sugar Prevention of rejection
- Overcoming the fourth barrier
- Preventing Chronic rejection
- At present no effective tx for chronic rejection
- Second transplantation
27The Humanized Pig Manipulating the genes of the
donor
- Genetic engineering Giving the pig human
genes(1) - Present technique
- Extremely inefficient
- 10 out of 100 embryos-1-2 transgenic
- Possible weak expression
- Present technique
- Superovulation
- Mating within 24 h
- Random needling of genes
- 25 embryos in 1 sow
- 1 fetus live birth
- sometimes with no expression
- Breeding
28(No Transcript)
29(No Transcript)
30The Humanized Pig Manipulating the genes of the
donor
- Genetic engineering Giving the pig human
genes(1) - Gal negative pigs
- Gal Knocking out Knocking out the sugar
- Oklahoma, Melbourne, Austin
- not available in pig
- GT KO in pig
- GAL KO in mice (Tony dApice from Melbourne
Australia) - Human serum still destroy the mouse organ
- Anti-non-Gal Ab
- Competing with Gal
- A gene for fucosyl transferase
- A gene for a-Galactosidase
31(No Transcript)
32(No Transcript)
33The Humanized Pig Manipulating the genes of the
donor
- Genetic engineering Giving the pig human
genes(2) - Protection against human complement
- hDAF
- MCP
- CD59
34The Humanized Pig Manipulating the genes of the
donor
- Cloning, the new technology
- Keith Campbell, Scottish biotechnology company,
PPL Therapeutics - Nuclear transfer technique into egg fetal or
embryo fibroblast - Single generation multiple off-springs
35(No Transcript)
36The Immunological Holy Grail Tolerance
- The limitations of present day 50 failure at
10y - The concept of tolerance
- Accept foreign without any long-term drug
therapy - Donor specific
- Not affecting host immune system
- No drug-related cancer development
- Free of acute or chronic rejection
37The Immunological Holy Grail Tolerance
- In search of tolerance (1)
- South African experience
- Johannes Myburgh, surgeon
- Total lymphoid irradiation(thymusLN) on
recipient baboon? Kidney transplantation from
donor baboon - Clinically not relevant
- The NIH-Harvard experience
- David Sachs successful induction of tolerance
in rodents - Ben Cosimi Bone marrow irradiation T-cell
cytotoxic drugsthymus irradiation insufficient - Plus BM transplantation from the same donor
chimeric immune system (mixed chimerism)? kidney
transplantation from the same donor - Controllable infection
38(No Transcript)
39The Immunological Holy Grail Tolerance
- In search of tolerance (2)
- Can we learn to tolerate pigs?
- B-cell toleranceabsent antibody production
- Anti-pig antibodies from B-cell/Plasma cell Ab
depletion required, irradiation resistant, - Gal-KO
- Molecular incompatibility
- Pig BM cell not proliferate well in baboon
stroma - Pig specific growth factor required
40The Immunological Holy Grail Tolerance
- Spontaneous unresponsiveness
- No rejection after cessation of
immunosuppressive drugs - Molecular chimerism (new concept)
- Pig genes for major antigen cloned, GT gene
- BM cell from recipient baboon aspirated
- Retroviral vector mediated pig gene transfection
into baboon cell - These cell back into baboon BM after whole body
irradiation - Pig kidney transplantation into baboon
- Induction of chimerism before birth
- All developing human fetus injected with pig
cells - For future pig organ transplantation
41The discordant concert Will the transplanted
organ work?
- Living out of ones elements
- Physiological biochemical difference
- Specific pig organs
- Electrolytes
- The effect of evolution
- Cholesterol
- Clot or bleed
- Growth hormone
- Aging of tissues
- Erythropoietin and red blood cells
- A new science Xenoincompatibility
42(No Transcript)
43The Hottest zone The fear of an AIDS-like epidemic
- The ever present fear
- Transplanting microbes
- The risk of cross-species infection
- Making the donor pig safe
- Monitoring for infectious organism
- Mad pig disease
- PERV
- Human factor
- Non-compliant patient
44Guinea pig The selection of the first patient
- Laboratory to hospital
- Are we ready for a clinical transplantation?
- A need to be identified
- An appropriate group of patient to be identified
- A sufficient experimental advances
- An ethical appropriateness
- Who are the most likely guinea pig?
- Those who have nothing to lose
- Back-up therapy available group
- Is the technology ready ?
- When will it happen?